[1]李丹青 肖强兵.巴戟天多糖通过p38 MAPK信号通路促间充质 干细胞成骨分化的体外研究[J].中国中医骨伤科杂志,2015,23(05):1-4.
　LI Danqing XIAO Qiangbin Hubei University of Chinese Medicine,Wuhan 00,China.Analysis of the Osteogenetic Effects Exerted on Mesenchymal Stem Cells by Morindae Officinalis Polysaccharide via p38 MAPK Signaling Pathway in Vitro[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2015,23(05):1-4.
点击复制

巴戟天多糖通过p38 MAPK信号通路促间充质 干细胞成骨分化的体外研究
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第23卷
期数:
2015年05期
页码:
1-4
栏目:
实验研究
出版日期:
2015-05-15

文章信息/Info

Title:
Analysis of the Osteogenetic Effects Exerted on Mesenchymal Stem Cells by Morindae Officinalis Polysaccharide via p38 MAPK Signaling Pathway in Vitro
文章编号:
1005-0205(2015)05-0001-04
作者:
李丹青1 肖强兵1

1.湖北中医药大学(武汉,430061)
Author(s):
LI Danqing1 XIAO Qiangbin1 1Hubei University of Chinese Medicine; Wuhan 430061; China
关键词:
巴戟天多糖;  间充质干细胞;  成骨分化;  p38MAPK
Keywords:
morindae officinalis polysaccharide;  bone marrow mesenchymal stem cells;  osteogenic differentiation;  p38MAPK
分类号:
R-33
文献标志码:
A
摘要:
目的:探讨巴戟天多糖对间充质干细胞(BMSCs)促成骨作用的影响及该作用与p38 MAPK信号通路的相关性。方法:体外骨髓贴壁法培养BMSCs,取第3代细胞,流式细胞仪鉴定细胞表面抗原。实验分为3组:1)对照组(经典成骨诱导),用地塞米松,β-甘油磷酸钠,VitC和无药血清的DMEM/F12培养基体外培养第3代的BMSCs; 2)巴戟天多糖(MOP)组,用含巴戟天多糖药物血清的DMEM/F12培养基体外培养第3代的BMSCs; 3)阻滞剂组(MOP+SB203580),用p38 MAPK的特异阻滞剂SB203580预干预细胞1 h后,加入含巴戟天多糖药物血清的DMEM/F12培养基体外培养第3代的BMSCs。体外培养3 d,蛋白印迹法检测p38及其磷酸化产物的蛋白表达及用SB203580阻断p38MAPK信号后巴戟天多糖对RUNX2,OPN的影响; 体外培养14 d,ALP活性试剂盒检测BMSCs的成骨分化情况; 体外培养21 d,茜素红染色检测BMSCs钙结节的情况。结果:100 g/L巴戟天多糖药物血清培养基为促(BMSCs)成骨的最佳浓度,差异有统计学意义(P<0.01); MOP组钙结节数量明显高于对照组和阻滞剂组,差异有统计学意义(P<0.01); 与对照组比较,巴戟天组能提高细胞RUNX2,OPN的蛋白表达,差异有统计学意义(P<0.01),提高了p38蛋白磷酸化表达,差异有统计学意义(P<0.05); p38特异性阻滞剂SB203580阻断p38 MAPK信号后巴戟天多糖促成骨作用明显下降,差异有统计学意义(P<0.01)。结论:巴戟天多糖能促进BMSCs成骨分化,其作用可能与激活p38蛋白的表达有关。
Abstract:
To investigate the effect of Morindae Officinalis polysaccharide(MOP)in promoting osteogenesis of rat bone marrow mesenchymal stem cells(MSCs)and the correlation with p38 MAPK signaling pathway.Methods:Rat BMSCs were cultured by adherence in vitro.The third generation of cells was collected.Cell surface antigen was identified by flow cytometry.The study includes three groups.1)The control group(classically osteogenic induction method):the third generation of cells were cultured by DMEM /F12 medium with dexamethasone, β-glycerophosphate, VitC and drug free serum in vitro.2)The MOP group:the third generation of cells were cultured by DMEM /F12medium with MOP in vitro.3)The blocker group(MOP+SB203580): the third generation of cells was pre-intervention by p38 MAPK specific blocker SB203580 for one hour then were cultured by DMEM/F12 medium with MOP in vitro.Western-blot was used to observe the protein and phosphorylation expression of p38 and the influence of MOP on RUNX2, OPN after p38 MAPK blocked by SB203580 after treatment with MOP for 3 days.After culture with different concentration of MOP for 14 days in vitro.Osteogenic differentiation of MSCs were detected by alkaline phosphatase(ALP)activity.Alizarin red staining was used to observe mineralized nodules of MSCs after treatment with MOP for 21 days.Results:MOP at a dose of 100 g/L,have the best ability to promote osteogenic differentiation on BMSCs with a significant statistically difference(P<0.01).Mineralized nodules of MOP group were obviously higher than the control group with a significant statistically difference(P<0.01 )and RUNX2,OPN of MOP group were obviously higher than the control group with a significant Statistically difference(P<0.01 )and Phospho-p38 of MOP group were higher than the control group with a Statistically difference(P<0.05).The indexs of the RUNX2,OPN in blocker group(MOP+SB203580)were less than those of MOP group(P<0.01)。Conclusion:MOP promotes differentiation of the mesenchymal stem cells into osteoblasts and its effect is related to the activation of p38 expression in the MAPK signaling pathway.

参考文献/References:

[1] 国家药典委员会.中华人民共和国药典(一部)[S].北京:中国医药科技出版社,2010:75-76.
[2] Zhou DA,Zheng HX,Wang CW,et al.Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells[J].BMC Musculoskelet Disord,2014,15:239.
[3] 王和鸣,王力,李楠.巴戟天对骨髓基质细胞向成骨细胞分化过程Cbfα1表达的影响[J].中国中医骨伤科杂志,2004,12(6):22-26.
[4] 李楠,王和鸣,郭素华,等.巴戟天多糖对体外培养成骨细胞核心结合因子α1mRNA 表达的影响[J].中华中医药杂志,2007,22(8):517-519.
[5] Aenlle KK,Curtis KM,Roos BA,et al.Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells[J].Mol Endocrinol,2014,28(5):722-730.
[6] 沈英超.巴戟天活性物质的研究[D].南京:南京林业大学,2008.
[7] Friedenstein AJ,Chailakhyan RK,Gerasimov UV.Bone marrow osteogenic stem cells:in vitro cultivation and transplantation in diffusion chambers[J].Cell Tissue Kinet,1987,20(3):263-272.
[8] 郭素华,王和鸣,黄涛,等.南靖巴戟天多糖的含量测定[J]福建中医学院学报,2006,16(1):32-33.
[9] 森立之重.神农本草经(卷下)[M].影印本.上海:上海卫生出版社,1957:93.
[10] 刘晓涵,陈永刚,林励,等.产地巴戟天中糖类成分H PLC-ELSD 指纹图谱研究[J].中草药,2009,40(10):1641-1643.
[11] 何剑全,陈健.巴戟天抗骨质疏松症作用机理的实验研究进展[J].世界中西医结合杂志,2010,10(6):546-548.
[12] 王斌,罗毅文,胡年宏.骨康方对大鼠MSCs体外向成骨细胞分化和ALP的影响[J].中国中医骨伤科杂志,2007,15(12):5-9.
[13] Bruderer M,Richards RG,Alini M,et al.Role and regulation of RUNX2 in osteogenesis [J].Eur Cell Mater,2014,28:269-286.
[14] Ye G,Li C,Xiang X,et al.Bone morphogenetic protein-9 induces PDLSCs osteogenic differentiation through the ERK and p38 signal pathways[J].Int J Med Sci,2014,11(10):1065-1072.
[15] Rodriguez-Carballo E,Gamez B,Sedo-Cabezon L,et al.The p38 alpha MAPK function in osteoprecursors is required for bone formation and bone homeostasis in adult mice[J].PLoS One,2014,9(7):e102032.
[16] Yang Z,Huang JH,Liu SF,et al.The osteoprotective effect of psoralen in ovariectomy-induced osteoporotic rats via stimulating the osteoblastic differentiation from bone mesenchymal stem cells[J].Menopause,2012,19(10):1156-1164.
[17] 毛项颖,卞琴,沈自尹.淫羊藿苷介导MAPK信号通路促进间充质干细胞株C3H10T1/2成骨分化的体外研究[J].中西医结合学报,2012,10(11):1272-1278.
[18] Suzuki A,Guicheux J,Palmer G,et al.Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation[J].Bone,2002,30(1):91-98.
[19] Matsuguchi T,Chiba N,Bandow K,et al.JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation[J].J Bone Miner Res,2009,24(3):398-410.
[20] Bao L,Qin L,Liu L,et al.Anthraquinone compounds from morinda officinalis inhibit osteoclastic bone resorption in vitro[J].Chem Biol Interact,2011,194(2-3):97-105.

备注/Memo

备注/Memo:
收稿日期:2014-10-06
更新日期/Last Update: 2015-05-15